Product
Cinacalcet
7 clinical trials
7 indications
Indication
HyperparathyroidismIndication
RenalIndication
Secondary HyperparathyroidismIndication
chronic kidney diseaseIndication
OsteoporosisIndication
Drug EffectIndication
Primary HyperparathyroidismClinical trial
A Multi-center Study Evaluating Efficacy and Safety of Cinacalcet Hydrochloride(HCL) in Calcium, Phosphorus and Intact Parathyroid Hormone(iPTH) Serum Levels in Chinese Chronic Kidney Disease(CKD) Hemodialysis(HD) Patients With Mild, Moderate and Severe Secondary Hyperparathyroidism(SHPT)Status: Completed, Estimated PCD: 2019-04-20
Clinical trial
An Open-label, Randomized, Active-Controlled Dose Titration Study to Assess the Efficacy and Safety of SHR6508 in Hemodialysis Subjects With Secondary HyperparathyroidismStatus: Active (not recruiting), Estimated PCD: 2023-10-31
Clinical trial
EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular EventsStatus: Completed, Estimated PCD: 2012-04-10
Clinical trial
Novel Combination Therapy for Osteoporosis in MenStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
A Multicenter, Randomised, Double-blind, Double-dummy Study to Assess the Efficacy and Safety of SHR6508 in Hemodialysis Subjects With Secondary HyperparathyroidismStatus: Not yet recruiting, Estimated PCD: 2025-06-01
Clinical trial
Parathyroid Hormone Level and Growth in Pediatric Patients With ESRD on Regular HemodialysisStatus: Completed, Estimated PCD: 2024-01-22
Clinical trial
Evaluating Alternative Medical Therapies in Primary HyperparathyroidismStatus: Completed, Estimated PCD: 2021-10-01